A Comparison of Linear Array and Hybrid Capture 2 for Detection of Carcinogenic HPV and Cervical Precancer in ALTS

摘要

BackgroundWe were interested in comparing the performance of Linear Array (LA; Roche Molecular Systems, Alameda, CA) to Hybrid Capture 2 (hc2; Digene Corporation, Gaithersburg, MD) for the detection of carcinogenic HPV and cervical precancer.